{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:44:11Z","timestamp":1794491051262,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fujian National Science Foundation","award":["2022J05331"],"award-info":[{"award-number":["2022J05331"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072213"],"award-info":[{"award-number":["82072213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971868"],"award-info":[{"award-number":["81971868"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Smart Health-care Project of Zhongshan Hospital","award":["2020ZHZS25"],"award-info":[{"award-number":["2020ZHZS25"]}]},{"name":"Post-graduate Medical Education Project of Shanghai Medical College Fudan University","award":["FDYXYBJ-20221003"],"award-info":[{"award-number":["FDYXYBJ-20221003"]}]},{"name":"Youth Fund of Zhongshan Hospital","award":["2021-011"],"award-info":[{"award-number":["2021-011"]}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic\/Technology Research Leader","doi-asserted-by":"crossref","award":["20XD1423000"],"award-info":[{"award-number":["20XD1423000"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Project of Zhongshan Hospital","award":["2020ZSLC41"],"award-info":[{"award-number":["2020ZSLC41"]}]},{"name":"Excellent Backbone Plan Of Zhongshan Hospital","award":["2021ZSGG16"],"award-info":[{"award-number":["2021ZSGG16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil. To date, there have been relatively few articles comparing RT and propofol for general anesthesia. This study aimed to assess the efficacy and safety of RT with or without flumazenil compared with propofol in general anesthesia for day surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>115 patients scheduled for day surgery were randomized into three groups: RT (n\u2009=\u200939), RT\u2009+\u2009flumazenil (n\u2009=\u200938) and propofol (n\u2009=\u200938). The primary endpoints were anesthesia induction time and time until fully alert. Anesthesia success rate, bispectral index (BIS) values, injection pain, opioid and vasopressor dosages, postoperative recovery profiles and perioperative inflammatory and cognitive changes were assessed. Any adverse events were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Induction times were similar among the three groups (P\u2009=\u20090.437), but the median time until fully alert in patients treated with RT was longer than that of the propofol or RT\u2009+\u2009flumazenil groups (17.6\u00a0min vs. 12.3\u00a0min vs. 12.3\u00a0min, P\u2009&lt;\u20090.001). The three groups had comparable postoperative recovery quality and inflammatory and cognitive state changes (P\u2009&gt;\u20090.05). Smaller percentages of patients who received RT (26.3%) and RT\u2009+\u2009flumazenil (31.6%) developed hypotension during anesthesia maintenance compared with propofol (68.4%), and consequently less ephedrine (P\u2009&lt;\u20090.001) and phenylephrine (P\u2009=\u20090.015) were needed in the RT group. Furthermore, serum triglyceride levels were lower (P\u2009&lt;\u20090.001) and injection pain was much less frequent in the RT with or without flumazenil groups compared with the propofol group (5.3% vs. 0% vs. 18.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RT permits rapid induction and comparable recovery profile compared with propofol in general anesthesia for day surgery, but has a prolonged recovery time without flumazenil. The safety profile of RT was superior to propofol in terms of hypotension and injection pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The study was registered at Chinese Clinical Trial Registry\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/\">http:\/\/www.chictr.org.cn\/<\/jats:ext-link>\n                      (Registration date: 19\/7\/2021; Trial ID: ChiCTR2100048904).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-023-02092-2","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:02:26Z","timestamp":1685066546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenchen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"6","key":"2092_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/anae.14639","volume":"74","author":"CR Bailey","year":"2019","unstructured":"Bailey CR, Ahuja M, Bartholomew K, Bew S, Forbes L, Lipp A, et al. Guidelines for day-case surgery 2019: guidelines from the Association of Anaesthetists and the British Association of Day surgery. Anaesthesia. 2019;74(6):778\u201392.","journal-title":"Anaesthesia"},{"issue":"1","key":"2092_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3892\/ijmm.2021.4968","volume":"48","author":"C Cui","year":"2021","unstructured":"Cui C, Zhang D, Sun K, Li H, Xu L, Lin G, et al. Propofol maintains Th17\/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR-145-3p\/NFATc2\/NF\u03baB axis. Int J Mol Med. 2021;48(1):135.","journal-title":"Int J Mol Med"},{"issue":"3","key":"2092_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jpainsymman.2010.07.001","volume":"40","author":"S Lundstr\u00f6m","year":"2010","unstructured":"Lundstr\u00f6m S, Twycross R, Mihalyo M, Wilcock A, Propofol. J Pain Symptom Manage. 2010;40(3):466\u201370.","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"2092_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1213\/ANE.0000000000000548","volume":"120","author":"KM Borkett","year":"2015","unstructured":"Borkett KM, Riff DS, Schwartz HI, Winkle PJ, Pambianco DJ, Lees JP, et al. A phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015;120(4):771\u201380.","journal-title":"Anesth Analg"},{"issue":"3","key":"2092_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0736-4679(97)00022-X","volume":"15","author":"SP Nordt","year":"1997","unstructured":"Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med. 1997;15(3):357\u201365.","journal-title":"J Emerg Med"},{"issue":"4","key":"2092_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491\u2013501.","journal-title":"J Anesth"},{"issue":"4","key":"2092_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34(4):543\u201353.","journal-title":"J Anesth"},{"key":"2092_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2147\/DDDT.S359496","volume":"16","author":"Y Mao","year":"2022","unstructured":"Mao Y, Guo J, Yuan J, Zhao E, Yang J. Quality of Recovery after General Anesthesia with Remimazolam in patients\u2019 undergoing urologic surgery: a randomized controlled trial comparing remimazolam with Propofol. Drug Des Devel Ther. 2022;16:1199\u2013209. Published 2022 Apr 27.","journal-title":"Drug Des Devel Ther"},{"key":"2092_CR9","doi-asserted-by":"crossref","unstructured":"Zhou Y, Hu P, Huang Y, Nuoer S, Song K, Wang H et al. \u201cPopulation Pharmacokinetic\/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects.\u201d Frontiers in pharmacology vol.\u00a09 1316. 19 Nov. 2018.","DOI":"10.3389\/fphar.2018.01316"},{"key":"2092_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","volume":"115","author":"HR Wiltshire","year":"2012","unstructured":"Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth Analg. 2012;115:284\u201396.","journal-title":"Anesth Analg"},{"issue":"2","key":"2092_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgh.15188","volume":"36","author":"SH Chen","year":"2021","unstructured":"Chen SH, Yuan TM, Zhang J, Bai H, Tian M, Pan CX, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol. 2021;36(2):474\u201381.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"2092_CR12","first-page":"4594","volume":"12","author":"S Chen","year":"2020","unstructured":"Chen S, Wang J, Xu X, Huang Y, Xue S, Wu A, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594\u2013603. Published 2020 Aug 15.","journal-title":"Am J Transl Res"},{"issue":"12","key":"2092_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1365-2044.1982.tb01782.x","volume":"37","author":"M Bahar","year":"1982","unstructured":"Bahar M, Dundee JW, O\u2019Neill MP, Briggs LP, Moore J, Merrett JD. Recovery from intravenous anaesthesia. Comparison of disoprofol with thiopentone and methohexitone. Anaesthesia. 1982;37(12):1171\u20135.","journal-title":"Anaesthesia"},{"issue":"9","key":"2092_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/aas.12381","volume":"58","author":"M Lindqvist","year":"2014","unstructured":"Lindqvist M, Schening A, Granstrom A, Bjorne H, Jakobsson JG. Cognitive recovery after ambulatory anaesthesia based on desflurane or propofol: a prospective randomised study. Acta Anaesthesiol Scand. 2014;58(9):1111\u201320.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"2092_CR15","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.apmr.2012.03.032","volume":"93","author":"AP Kontos","year":"2012","unstructured":"Kontos AP, Covassin T, Elbin RJ, Parker T. Depression and neurocognitive performance after concussion among male and female high school and collegiate athletes. Arch Phys Med Rehabil. 2012;93(10):1751\u20136.","journal-title":"Arch Phys Med Rehabil"},{"key":"2092_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijsu.2018.11.022","volume":"61","author":"K Dahlberg","year":"2019","unstructured":"Dahlberg K, Jaensson M, Nilsson U. Let the patient decide\u201d - person-centered postoperative follow-up contacts, initiated via a phone app after day surgery: secondary analysis of a randomized controlled trial. Int J Surg. 2019;61:33\u20137.","journal-title":"Int J Surg"},{"issue":"3","key":"2092_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.smrv.2009.09.001","volume":"14","author":"M Dyzma","year":"2010","unstructured":"Dyzma M, Boudjeltia KZ, Faraut B, Kerkhofs M. Neuropeptide Y and sleep. Sleep Med Rev. 2010;14(3):161\u20135.","journal-title":"Sleep Med Rev"},{"key":"2092_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/B978-0-443-06959-8.00026-1","volume-title":"Miller\u2019s anesthesia","author":"JG Reves","year":"2010","unstructured":"Reves JG, Glass P, lubarsky D, Matthe WD, Evoy MC, Martinez R, et al. Intravenous anesthetics. In: Miller RD, editor. Miller\u2019s anesthesia. 7th ed. San Francisco: Elsevier; 2010. pp. 719\u201368.","edition":"7"},{"key":"2092_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2147\/IJGM.S345390","volume":"15","author":"F Shi","year":"2022","unstructured":"Shi F, Chen Y, Li H, Zhang Y, Zhao T. Efficacy and safety of Remimazolam Tosilate versus Propofol for General Anesthesia in Cirrhotic Patients undergoing endoscopic Variceal Ligation. Int J Gen Med. 2022;15:583\u201391. Published 2022 Jan 13.","journal-title":"Int J Gen Med"},{"issue":"6","key":"2092_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/bja\/aep269","volume":"103","author":"RN Upton","year":"2009","unstructured":"Upton RN, Martinez AM, Grant C. Comparison of the sedative properties of CNS 7056, midazolam, and propofol in sheep. Br J Anaesth. 2009;103(6):848\u201357.","journal-title":"Br J Anaesth"},{"issue":"3","key":"2092_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00540-010-0907-4","volume":"24","author":"W Miyake","year":"2010","unstructured":"Miyake W, Oda Y, Ikeda Y, Hagihira S, Iwaki H, Asada A. Electroencephalographic response following midazolam-induced general anesthesia: relationship to plasma and effect-site midazolam concentrations. J Anesth. 2010;24(3):386\u201393.","journal-title":"J Anesth"},{"issue":"4","key":"2092_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/00000542-199704000-00014","volume":"86","author":"PS Glass","year":"1997","unstructured":"Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology. 1997;86(4):836\u201347.","journal-title":"Anesthesiology"},{"issue":"2","key":"2092_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00540-021-03030-7","volume":"36","author":"K Shirozu","year":"2022","unstructured":"Shirozu K, Nobukuni K, Tsumura S, Imura K, Nakashima K, Takamori S, et al. Neurological sedative indicators during general anesthesia with remimazolam. J Anesth. 2022;36(2):194\u2013200.","journal-title":"J Anesth"},{"issue":"10","key":"2092_CR24","first-page":"946","volume":"41","author":"D Guan Ren","year":"2020","unstructured":"Guan Ren D, Xiwei M, Ning Z. Pharmacologic overview of the innovative soft drug remimazolam based on computer simulation. Int J Anesth Resus. 2020;41(10):946\u201354.","journal-title":"Int J Anesth Resus"},{"issue":"10212","key":"2092_CR25","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(19)32315-3","volume":"394","author":"TG Short","year":"2019","unstructured":"Short TG, Campbell D, Frampton C, et al. Anaesthetic depth and complications after major surgery: an international, randomised controlled trial. Lancet. 2019;394(10212):1907\u201314.","journal-title":"Lancet"},{"issue":"1","key":"2092_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, et al. Safety and Efficacy of Remimazolam compared with placebo and midazolam for moderate Sedation during Bronchoscopy. Chest. 2019;155(1):137\u201346.","journal-title":"Chest"},{"issue":"1","key":"2092_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13054-022-04168-w","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, Shu H, Yuan Y, Liu H, et al. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care. 2022;26(1):279. Published 2022 Sep 16.","journal-title":"Crit Care"},{"key":"2092_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2020.05.018","volume":"139","author":"E Rudnicka","year":"2020","unstructured":"Rudnicka E, Napiera\u0142a P, Podfigurna A, M\u0119czekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6\u201311.","journal-title":"Maturitas"},{"issue":"11","key":"2092_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1377\/hlthaff.2013.0714","volume":"32","author":"TM Dall","year":"2013","unstructured":"Dall TM, Gallo PD, Chakrabarti R, West T, Semilla AP, Storm MV. An aging population and growing disease burden will require a large and specialized health care workforce by 2025. Health Aff (Millwood). 2013;32(11):2013\u201320.","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"2092_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1447-0594.2006.00341.x","volume":"6","author":"H Orimo","year":"2006","unstructured":"Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of \u201celderly. Geriatr Gerontol Int. 2006;6(3):149\u201358.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"2092_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.resuscitation.2006.11.010","volume":"74","author":"AS Ngo","year":"2007","unstructured":"Ngo AS, Anthony CR, Samuel M, Wong E, Ponampalam R. Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department? Resuscitation. 2007;74(1):27\u201337.","journal-title":"Resuscitation"},{"issue":"1","key":"2092_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bcpt.12434","volume":"118","author":"EI Penninga","year":"2016","unstructured":"Penninga EI, Graudal N, Ladekarl MB, J\u00fcrgens G. Adverse events Associated with Flumazenil Treatment for the management of suspected Benzodiazepine Intoxication\u2013A systematic review with Meta-analyses of Randomised trials. Basic Clin Pharmacol Toxicol. 2016;118(1):37\u201344.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2092_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/1751-2980.12579","volume":"19","author":"SP Lee","year":"2018","unstructured":"Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. Efficacy and safety of flumazenil injection for the reversal of midazolam sedation after elective outpatient endoscopy. J Dig Dis. 2018;19(2):93\u2013101.","journal-title":"J Dig Dis"},{"issue":"6","key":"2092_CR34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/bja\/66.6.660","volume":"66","author":"RD Jones","year":"1991","unstructured":"Jones RD, Lawson AD, Andrew LJ, Gunawardene WM, Bacon-Shone J. Antagonism of the hypnotic effect of midazolam in children: a randomized, double-blind study of placebo and flumazenil administered after midazolam-induced anaesthesia. Br J Anaesth. 1991;66(6):660\u20136.","journal-title":"Br J Anaesth"},{"issue":"1","key":"2092_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/imr.12373","volume":"269","author":"F Rosetti","year":"2016","unstructured":"Rosetti F, Mayadas TN. The many faces of Mac-1 in autoimmune disease. Immunol Rev. 2016;269(1):175\u201393.","journal-title":"Immunol Rev"},{"issue":"1\u20132","key":"2092_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jim.2011.04.004","volume":"369","author":"PJ Schuler","year":"2011","unstructured":"Schuler PJ, Harasymczuk M, Schilling B, Lang S, Whiteside TL. Separation of human CD4 + CD39 + T cells by magnetic beads reveals two phenotypically and functionally different subsets. J Immunol Methods. 2011;369(1\u20132):59\u201368.","journal-title":"J Immunol Methods"},{"key":"2092_CR37","doi-asserted-by":"crossref","unstructured":"Nummela AJ, Laaksonen LT, Laitio TT, Kallionp\u00e4\u00e4 RE, L\u00e5ngsj\u00f6 JW, Scheinin JM, et al. Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: a randomised trial using nuclear magnetic resonance spectroscopy. Eur J Anaesthesiol. 2022 Jun;1:39:521\u201332.","DOI":"10.1097\/EJA.0000000000001591"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-02092-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:03:00Z","timestamp":1685066580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-02092-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2092"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-02092-2","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Zhongshan Hospital (Number B2021\u2013360) and was registered with the Chinese Clinical Trial Registry prior to patient enrollment (ChiCTR2100048904; Principal investigator: CM; Date of registration: July 19, 2021). The trial was modified on September 23, 2021 to add an additional arm to test RT\u2009+\u2009flumazenil. Patients were recruited from October 2021 to December 2021 at Zhongshan Hospital Fudan University, Shanghai, China. Written informed consent was obtained from all participants included in the study. This manuscript adheres to the applicable Consolidated Standards of Reporting Trials guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}